Skip to main content
. Author manuscript; available in PMC: 2009 Sep 7.
Published in final edited form as: Stem Cells. 2008 Sep 18;26(12):3027–3036. doi: 10.1634/stemcells.2007-1073

Table 1.

T3359 CD133+
Treatment 10,000 cells 1,000 cells
Control (DMSO) Incidence: 3/3
Median Survival: 24 days
Incidence: 3/3
Median Survival: 35 days
25 uM AktIII inhibitor Incidence: 3/3
Median Survival: 40 days
Incidence: 2/3
Median Survival: 66 days